Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02802384 · ClinicalTrials.gov registry record
Pathophysiology of Paget's Disease of Bone
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 11
- Enrollment target
NCT02802384: Completed study, sponsored by Johns Hopkins University.
NCT02802384 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02802384 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
Paget's disease of the bone is a skeletal disorder which results in increased and disorganized bone remodeling, leading to dense but fragile and expanding bones. The identified genetic causes of Paget's disease of bone only explain why bone is destroyed, but not why the bone formed in its place is abnormal. Current treatment for people with Paget's disease of the bone is limited to patients with bone pain, thought to be related to high rate of bone turnover (breakdown and rebuilding of bone) and works by slowing down the rate of bone breakdown. The current treatment does not address the excess blood vessels and bone formed. This research is being done to understand factors that may promote blood vessel and bone formation in Paget's disease of the bone.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2016-04 |
| Est. Completion | 2024-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02802384
The ClinicalTrials.gov registry entry for NCT02802384 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02802384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02802384 about?
NCT02802384 is a clinical study titled "Pathophysiology of Paget's Disease of Bone". Paget's disease of the bone is a skeletal disorder which results in increased and disorganized bone remodeling, leading to dense but fragile and expanding bones. The identified genetic causes of Paget's disease of bone only explain why bone is destroyed, but not why the bone formed in its place is a...
What is the current status of trial NCT02802384?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2016-04. Estimated completion is 2024-03.
Who is sponsoring clinical trial NCT02802384?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.